Salivary Calcium As a Diagnostic Tool for Screening of Osteoporosis in Postmenopausal Women

Overview

Journal J Oral Maxillofac Pathol

Date 2019 Sep 14

PMID 31516222

Citations 2

Authors

Shweta Vinayak Kumbhojkar

Alka Dinesh Kale

Vinayak R Kumbhojkar

Karishma Madhusudan Desai

Affiliations

Soon will be listed here.

Abstract

Background: Women's health undergoes physiological, pathological and psychological changes after menopause. Reduced estrogen levels have been implicated in the pathogenesis of osteoporosis in postmenopausal women. Estrogen is also known to affect the salivary gland functions. To understand the association between serum estrogen, osteoporosis and salivary calcium, the present cross-sectional study was undertaken.

Aim: The aim of this study is to determine salivary calcium levels and its use for the diagnosis of osteoporosis in postmenopausal women.

Methodology: Ninety individuals divided into three groups of healthy controls, pregnant women and postmenopausal women were selected. Serum estrogen, salivary calcium and bone mineral density (BMD) at the heel region were estimated. Statistical analysis using the Mann-Whitney U-test was done to compare the results within the groups.

Results: Mean estrogen levels were 115.8 ± 80.18 pg/mmol in control group, 7729.4 ± 907.6 pg/mmol in pregnant group and 51.2 ± 74.51 pg/mmol in postmenopausal group, respectively. The mean salivary calcium in control, pregnant and postmenopausal groups was 3.12 ± 0.63, 3.19 ± 0.62 and 7.12 ± 0.79 μg/dl, respectively. Paired comparison within the groups showed high statistical significance ( = 0.0000) in the salivary calcium levels. The mean BMD of -2.3 (standard deviation [SD] ± 0.83) in the postmenopausal group was significantly lower than -0.6 (SD ± 0.99) and -0.2 (SD ± 1.42) of pregnant and control groups, respectively.

Conclusion: A negative correlation was found between estrogen and bone density. A significant difference in salivary calcium was noted in the study groups, highlighting the role of salivary calcium in the detection of early bone changes in postmenopausal women.

Citing Articles

Menopause and Oral Health: Clinical Implications and Preventive Strategies.

Shrivastava S J Midlife Health. 2024; 15(3):135-141.

PMID: 39610962 PMC: 11601932. DOI: 10.4103/jmh.jmh_125_24.

Composition and Properties of Saliva in Patients with Osteoporosis Taking Antiresorptive Drugs.

Sobczak-Jaskow H, Kochanska B, Drogoszewska B Int J Environ Res Public Health. 2023; 20(5).

PMID: 36901300 PMC: 10002130. DOI: 10.3390/ijerph20054294.

References

Sewon L, Laine M, Karjalainen S, Hiidenkari T, Helenius H . The effect of hormone replacement therapy on salivary calcium concentrations in menopausal women. Arch Oral Biol. 2000; 45(3):201-6. DOI: 10.1016/s0003-9969(99)00137-5. View

Schilling A, Laszlo D . Investigative tools in the study of calcium metabolism in man: balance studies, the calcium tolerance test, radioactive calcium, and complexing agents. Oral Surg Oral Med Oral Pathol. 1953; 6(1):139-46. DOI: 10.1016/0030-4220(53)90149-2. View

Nagler R, Hershkovich O . Relationships between age, drugs, oral sensorial complaints and salivary profile. Arch Oral Biol. 2004; 50(1):7-16. DOI: 10.1016/j.archoralbio.2004.07.012. View

Agha-Hosseini F, Mirzaii-Dizgah I, Moghaddam P, Akrad Z . Stimulated whole salivary flow rate and composition in menopausal women with oral dryness feeling. Oral Dis. 2007; 13(3):320-3. DOI: 10.1111/j.1601-0825.2006.01288.x. View

Tohme J, Bilezikian J, Clemens T, Silverberg S, Shane E, Lindsay R . Suppression of parathyroid hormone secretion with oral calcium in normal subjects and patients with primary hyperparathyroidism. J Clin Endocrinol Metab. 1990; 70(4):951-6. DOI: 10.1210/jcem-70-4-951. View

Baccaro L, Conde D, Costa-Paiva L, Pinto-Neto A . The epidemiology and management of postmenopausal osteoporosis: a viewpoint from Brazil. Clin Interv Aging. 2015; 10:583-91. PMC: 4374649. DOI: 10.2147/CIA.S54614. View

Singh S, Sikri G, Garg M . Body Mass Index and Obesity : Tailoring "cut-off" for an Asian Indian Male Population. Med J Armed Forces India. 2016; 64(4):350-3. PMC: 5035251. DOI: 10.1016/S0377-1237(08)80019-6. View

Ferguson D . Current diagnostic uses of saliva. J Dent Res. 1987; 66(2):420-4. DOI: 10.1177/00220345870660020601. View

Riggs B, Melton 3rd L . Involutional osteoporosis. N Engl J Med. 1986; 314(26):1676-86. DOI: 10.1056/NEJM198606263142605. View

10.

Puskulian L . Salivary electrolyte changes during the normal menstrual cycle. J Dent Res. 1972; 51(5):1212-6. DOI: 10.1177/00220345720510050701. View

11.

. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser. 1994; 843:1-129. View

12.

Ben Aryeh H, Gottlieb I, Ish-Shalom S, David A, Szargel H, Laufer D . Oral complaints related to menopause. Maturitas. 1996; 24(3):185-9. DOI: 10.1016/s0378-5122(96)82008-1. View

13.

Helenius H, Laine M . Hormone replacement therapy and some salivary antimicrobial factors in post- and perimenopausal women. Maturitas. 1997; 27(2):145-51. DOI: 10.1016/s0378-5122(97)00024-8. View

14.

Jeffcoat M . Osteoporosis: a possible modifying factor in oral bone loss. Ann Periodontol. 1998; 3(1):312-21. DOI: 10.1902/annals.1998.3.1.312. View

15.

Sewon L, Karjalainen S, Soderling E, Lapinleimu H, Simell O . Associations between salivary calcium and oral health. J Clin Periodontol. 1998; 25(11 Pt 1):915-9. DOI: 10.1111/j.1600-051x.1998.tb02390.x. View